Loading data for BHC.TO — first visit, this takes a few seconds.

Bausch Health Companies Inc. (BHC.TO)

Toronto: BHC.TO · 即時價格 · USD

9.01

+0.22 (2.50%)

收盤價： Sep 04, 2026, 8:00 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

無可用資料

買價	9
市值	3.39B
營收 (ttm)	10.9B
淨利（ttm）	-1.1B
	0.37
	-4.07
	n/a
	1.56
P/B (ttm)	-1.38
P/S (ttm)	0.31
財報日期	Oct 28, 2026

賣價	9.01
成交量	512,740
20 日平均成交量	680,825
開盤價	8.80
前收盤價	8.79
當日區間	8.80 - 9.35
52 週範圍	6.10 - 11.08
分析師	n/a
目標價	n/a
股利	n/a
除息日	Nov 10, 2010

關於 BHC.TO

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter prod...

類股 Healthcare

IPO 日期 Apr 3, 1996

員工 20,300

證券交易所 Toronto

股票代號 BHC.TO

網站 https://www.bauschhealth.com

完整的公司簡介

財務表現

Bausch Health Companies 在 2025 年的營收為 10.27B，較前一年的 9.63B 增加 6.66%。淨利為 157M，較前期減少 -441.3%。

CAD 中的財務資料財務報表

財報驚奇

Bausch Health Companies 已於 Jul 29, 2026 公布季度財報：

營收為 $2.85B 低於預期 $0, 年增 12.73% 成長.
每股盈餘為 1.26 超出預期 0.25, 年增 38.46% 成長.

下次財報發布

Bausch Health Companies Inc. 的下次財報預計於 Oct 28, 2026, 收盤後。
分析師預估營收 ... 升級

價格為何變動

新聞動態

2 週前 · Zacks

Can Bausch (BHC) Run Higher on Rising Earnings Estimates?

Bausch Health (BHC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

2 週前 · Zacks

Bausch (BHC) Upgraded to Buy: Here's What You Should Know

Bausch (BHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 月前 · Motley Fool

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month

Much of this was due to a very well-received quarterly earnings report.

1 月前 · Insider Monkey

Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook

Bausch Health (NYSE:BHC) climbed by 28.85 percent on Thursday to end at $6.03 apiece, after announcing a strong second quarter of the year that set the ground for the company’s profit recovery. In an ...

1 月前 · Zacks

BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised

BHC beats Q2 estimates as Salix, Solta Medical and Bausch + Lomb fuel growth, lifting 2026 revenue and EBITDA guidance after strong earnings.

第 1 頁，共 2 頁

Bausch Health Companies Inc. (BHC.TO)